Conditional Ablation of the Heparan Sulfate-synthesizing Enzyme Ext1 Leads to Dysregulation of Bone Morphogenic Protein Signaling and Severe Skeletal Defects
Yoshihiro Matsumoto(Jikei University Kashiwa hospital), Yu Yamaguchi(Sanford Burnham Prebys Medical Discovery Institute)
Cited by 62
Related Papers
Glypican‐4 is an FGF2‐binding heparan sulfate proteoglycan expressed in neural precursor cells
|Developmental Dynamics|2000|94
Netrin-1/DCC Signaling in Commissural Axon Guidance Requires Cell-Autonomous Expression of Heparan Sulfate
|Journal of Neuroscience|2007|83
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma
|European Journal of Cancer|2019|79
Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study
|World Journal of Surgical Oncology|2018|55
Rab44, a novel large Rab GTPase, negatively regulates osteoclast differentiation by modulating intracellular calcium levels followed by NFATc1 activation
|Cellular and Molecular Life Sciences|2017|45